|
87
|
290
|
4wovA |
Crystal structure of tyrosine kinase 2 jh2 (pseudo kinase domain) complexed with bms-066 aka 2-methoxy-n-({6-[3-methyl-7-(methylamino)-3,5,8,10-tetraazatricyclo[7.3.0.0, 6]dodeca-1(9),2(6),4,7,11-pentaen-11-yl]pyridin-2-yl}methy l)acetamide |
|
92
|
317
|
4wsqA |
Crystal structure of adaptor protein 2 associated kinase (aak1) in complex with small molecule inhibitor |
|
93
|
290
|
4wnmA |
Syk catalytic domain in complex with a potent triazolopyridine inhibitor |
|
66
|
256
|
4x7qA |
Pim2 kinase in complex with compound 1s |
|
108
|
355
|
4x21A |
The map kinase jnk3 as target for halogen bonding |
|
89
|
301
|
4wunA |
Structure of fgfr1 in complex with azd4547 (n-{3-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-5-yl}-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide) at 1.65 angstrom |
|
79
|
267
|
4uynA |
Sar156497 an exquisitely selective inhibitor of aurora kinases |
|
115
|
353
|
4wihA |
Crystal structure of camp-dependent protein kinase a from cricetulus griseus |
|
95
|
329
|
4umqA |
Structure of melk in complex with inhibitors |
|
163
|
465
|
4wg4A |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1613 |
|
95
|
291
|
4w8eA |
Structure of mst3 with a pyrrolopyrimidine inhibitor (pf-06645342) |
|
170
|
518
|
4wnkA |
Crystal structure of bovine g protein coupled-receptor kinase 5 in complex with ccg215022 |
|
107
|
350
|
4x6rA |
An isoform-specific myristylation switch targets riib pka holoenzymes to membranes |
|
103
|
356
|
4w4vA |
Jnk2/3 in complex with 3-(4-{[(2-chlorophenyl)carbamoyl]amino}-1h-pyrazol-1-yl)-n-(2-methylpyridin-4-yl)benzamide |
|
100
|
303
|
4x2kA |
Selection of fragments for kinase inhibitor design: decoration is key |
|
111
|
356
|
4w4wA |
Jnk2/3 in complex with n-(2-methylpyridin-4-yl)-3-{4-[(phenylcarbamoyl)amino]-1h-pyrazol-1-yl}benzamide |
|
100
|
303
|
4x2jA |
Selection of fragments for kinase inhibitor design: decoration is key |
|
88
|
302
|
4v05A |
Fgfr1 in complex with azd4547. |
|
86
|
273
|
4wnoA |
Structure of ulk1 bound to an inhibitor |
|
81
|
274
|
4wnpA |
Structure of ulk1 bound to a potent inhibitor |
|
80
|
288
|
4x3fC |
Crystal structure of the intracellular domain of the m. tuberculosis ser/thr kinase pkna |
|
101
|
356
|
4w4xA |
Jnk2/3 in complex with 3-(4-{[(4-fluorophenyl)carbamoyl]amino}-1h-pyrazol-1-yl)-n-(2-methylpyridin-4-yl)benzamide |
|
101
|
303
|
4x2nA |
Selection of fragments for kinase inhibitor design: decoration is key |
|
78
|
273
|
4wrsA |
Crystal structure of human pim-1 kinase in complex with an azaspiro pyrazinyl-indazole inhibitor. |
|
91
|
277
|
4rx9A |
Syk catalytic domain complexed with a potent pyrimidine inhibitor |
|
91
|
294
|
4tw9A |
Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of ck1delta and epsilon with nanomolar inhibitory activity on cancer cell proliferation |
|
86
|
319
|
4u80A |
Mek 1 kinase bound to g799 |
|
104
|
351
|
4s34A |
Erk2 (i84a) in complex with amp-pnp |
|
86
|
322
|
4u81A |
Mek1 kinase bound to small molecule inhibitor g659 |
|
111
|
351
|
4s2zA |
Erk2 intrinsically active mutant r65s |
|
90
|
308
|
4rwjA |
Crystal structure of fgfr1 (c488a, c584s) in complex with azd4547 (n-{3-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-5-yl}-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide) |
|
82
|
295
|
4u3zA |
Apo map4k4 t181e phosphomimetic mutant |
|
89
|
275
|
4rx8A |
Syk catalytic domain complexed with a potent triazine inhibitor2 |
|
88
|
276
|
4txcA |
Crystal structure of dapk1 kinase domain in complex with a small molecule inhibitor |
|
107
|
333
|
4ubaA |
Low-salt structure of protein kinase ck2 catalytic subunit with 4'-carboxy-6,8-bromo-flavonol (flc26) |
|
55
|
290
|
4tthB |
Crystal structure of a cdk6/vcyclin complex with inhibitor bound |
|
67
|
273
|
4rzvA |
Crystal structure of the braf (r509h) kinase domain monomer bound to vemurafenib |
|
79
|
275
|
4u5jA |
C-src in complex with ruxolitinib |
|
71
|
273
|
4rzwA |
Crystal structure of braf (r509h) kinase domain bound to az628 |
|
84
|
308
|
4tygA |
Structural analysis of the human fibroblast growth factor receptor 4 kinase |
|
94
|
348
|
4tyhB |
Ternary complex of p38 and mk2 with a p38 inhibitor |
|
96
|
297
|
4twnA |
Human epha3 kinase domain in complex with birb796 |
|
99
|
350
|
4tyhA |
Ternary complex of p38 and mk2 with a p38 inhibitor |
|
94
|
290
|
4u8zA |
Crystal structure of mst3 with a pyrrolopyrimidine inhibitor (pf-06447475) |
|
87
|
301
|
4rwlA |
Crystal structure of fgfr1 (c488a, c584c) in complex with 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide (e3810) |
|
106
|
357
|
4u79A |
Crystal structure of human jnk3 in complex with a benzenesulfonamide inhibitor. |
|
81
|
298
|
4u43A |
Map4k4 in complex with inhibitor (compound 6) |
|
90
|
305
|
4rwiA |
Crystal structure of v561m fgfr1 gatekeeper mutation (c488a, c584s, v561m), apo |
|
79
|
273
|
4ty1A |
Crystal structure of human pim-1 kinase in complex with an aminooxadiazole-indole inhibitor. |
|
84
|
271
|
4twpA |
The crystal structure of human abl1 t315i gatekeeper mutant kinase domain in complex with axitinib |
